1.Holick MF. The vitamin D deficiency pandemic and consequences for nonskeletal health: mechanisms of action. Molecular Aspects of Medicine 2008; 29: 361–368.
2.Bikle DD. Vitamin D and the immune system: role in protection against bacterial infection. Current Opinion in Nephrology and Hypertension 2008; 17: 348–352.
3.Feindt E, Ströder J. Studies on the antimicrobial effect of vitamin D. Wiener Klinische Wochenschrift 1977; 55: 507–508.
4.Roth DE, et al. Vitamin D receptor polymorphisms and the risk of acute lower respiratory tract infection in early childhood. Journal of Infectious Diseases 2008; 197: 676–680.
5.Karatekin G, et al. Association of subclinical vitamin D deficiency in newborns with acute lower respiratory infection and their mothers. European Journal of Clinical Nutrition 2009; 63: 473–477.
6.De la Torre MS, et al. Vitamin D receptor gene haplotypes and susceptibility to HIV-1 infection in injection drug users. Journal of Infectious Diseases 2008; 197: 405–410.
7.Li JH, et al. Study on association between vitamin D receptor gene polymorphisms and the outcomes of HBV infection. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2006; 23: 402–405.
8.Liu PT, et al. Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. Journal of Immunology 2007; 179: 2060–2063.
9.O'Connor KA, et al. Antibiotic prescribing policy and Clostridium difficile diarrhoea. Quarterly Journal of Medicine 2004; 97: 423–429.
10.Gravel D, et al. Health care-associated Clostridium difficile infection in adults admitted to acute care hospitals in Canada: a Canadian Nosocomial Infection Surveillance Program Study. Clinical Infectious Diseases 2009; 48: 568–576.
11.Bujanda L, Cosme A. Clostridium difficile-associated diarrhea. Journal of Gastroenterology and Hepatology 2009; 32: 48–56.
12.Dubberke ER, Wertheimer AI. Review of current literature on the economic burden of Clostridium difficile infection. Infection Control and Hospital Epidemiology 2009; 30: 57–66.
13.Noskin GA, et al. Budget impact analysis of rapid screening for Staphylococcus aureus colonization among patients undergoing elective surgery in US hospitals. Infection Control and Hospital Epidemiology 2008; 29: 16–24.
14.Engemann JJ, et al. Clinical outcomes and costs due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysis. Infection Control and Hospital Epidemiology 2005; 26: 534–539.
15.Rubin RJ, et al. The economic impact of Staphylococcus aureus infection in New York City hospitals. Emerging Infectious Diseases 1999; 5: 9–17.
16.Peiris AN, Bailey BA, Manning T. The relationship of vitamin D deficiency to health care costs in veterans. Military Medicine 2008; 173: 1214–1218.
17.Napier RH, et al. Insurance billing and coding. Dental Clinics of North America 2008; 52: 507–27, viii.
18.Bodnar LM, Krohn MA, Simhan HN. Maternal vitamin D deficiency is associated with bacterial vaginosis in the first trimester of pregnancy. Journal of Nutrition 2009; 139: 1157–1161.
19.Nasri H, Baradaran A. The influence of serum 25-hydroxy vitamin D levels on Helicobacter pylori infections in patients with end-stage renal failure on regular hemodialysis. Saudi Journal of Kidney Diseases and Transplantation 2007; 18: 215–219.
20.Haug C, et al. Subnormal serum concentration of 1,25-vitamin D in human immunodeficiency virus infection: correlation with degree of immune deficiency and survival. Journal of Infectious Diseases 1994; 169: 889–893.
21.Ginde AA, Mansbach JM, Camargo CA Jr.. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Archives of Internal Medicine 2009; 169: 384–390.
22.Wayse V, et al. Association of subclinical vitamin D deficiency with severe acute lower respiratory infection in Indian children under 5 y. European Journal of Clinical Nutrition 2004; 58: 563–567.
23.Li-Ng M, et al. A randomized controlled trial of vitamin D3 supplementation for the prevention of symptomatic upper respiratory tract infections. Epidemiology and Infection 2009; 137: 1396–1404.
24.Leandro AC, et al. Genetic polymorphisms in vitamin D receptor, vitamin D-binding protein, Toll-like receptor 2, nitric oxide synthase 2, and interferon-gamma genes and its association with susceptibility to tuberculosis. Brazilian Journal of Medical and Biological Research 2009; 42: 312–322.
25.Wilbur AK, et al. Vitamin D receptor gene polymorphisms and susceptibility M. tuberculosis in native Paraguayans. Tuberculosis (Edinburgh) 2007; 87: 329–337.
26.Huff GR, et al. Effect of dietary supplementation with vitamin D metabolites in an experimental model of turkey osteomyelitis complex. Poultry Science 2002; 81: 958–965.
27.Silva ME, et al. Vitamin D overload and experimental Trypanosoma cruzi infection: parasitological and histopathological aspects. Comparative Biochemistry and Physiology 1993; 104: 175–181.
28.Gombart AF, Borregaard N, Koeffler HP. Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. FASEB Journal 2005; 19: 1067–1077.
29.Leventis P, Kiely PD. The tolerability and biochemical effects of high-dose bolus vitamin D2 and D3 supplementation in patients with vitamin D insufficiency. Scandinavian Journal of Rheumatology 2009; 38: 149–153.
30.Doll R, Hill AB. Smoking and carcinoma of the lung. Preliminary report. 1950. Bulletin of the World Health Organization 1999; 77: 84–93.
31.Scragg R, Khaw KT, Murphy S. Life-style factors associated with winter serum 25-hydroxyvitamin D levels in elderly adults. Age and Ageing 1995; 24: 271–275.
32.Sedrani SH. Low 25-hydroxyvitamin D and normal serum calcium concentrations in Saudi Arabia: Riyadh region. Annals of Nutrition and Metabolism 1984; 28: 181–185.
33.Jeng L, et al. Alterations in vitamin D status and anti-microbial peptide levels in patients in the intensive care unit with sepsis. Journal of Translational Medicine 2009; 7: 28.
34.Ginde AA, Liu MC, Camargo CA Jr.. Demographic differences and trends of vitamin D insufficiency in the US population, 1988–2004. Archives of Internal Medicine 2009; 169: 626–632.
35.Autier P, Gandini S. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Archives of Internal Medicine 2007; 167: 1730–1737.
36.Grant WB, et al. Estimated benefit of increased vitamin D status in reducing the economic burden of disease in Western Europe. Progress in Biophysics and Molecular Biology 2009; 99: 104–113.